XBIT
NASDAQ
$2.25
XBiotech Inc (XBIT)
XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. The company is headquartered in Austin, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Target: $18 (+700.00%)
Market Cap
$70M
P/B Ratio
0.52
EPS 5Y CAGR
+22.81%
Free Cash Flow Yield
-60.68%
Price Chart
Valuation
Market Cap$70M
P/S12.23
P/B0.52
Profitability
Total Revenue (TTM)$5.09M
Gross Profit (TTM)$3.36M
EBITDA-$47M
EPS-$1.32
Financial Health
Free Cash Flow Yield-60.68%
Growth & Risk
EPS 5Y CAGR+22.81%
Revenue 5Y CAGR-32.44%
Beta (5Y)1.27
Sharpe Ratio-0.44